Skip Navigation


Annals of Oncology Advance Access originally published online on February 13, 2007
Annals of Oncology 2007 18(5):945-949; doi:10.1093/annonc/mdl499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/5/945    most recent
mdl499v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ayantunde, A.
Right arrow Articles by Parsons, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayantunde, A.
Right arrow Articles by Parsons, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

palliative care

Pattern and prognostic factors in patients with malignant ascites: a retrospective study

AA Ayantunde* and SL Parsons

Department of Surgery, Nottingham University Hospitals, Nottingham City Hospital Campus, Nottingham, UK

* Correspondence to: Dr A. A. Ayantunde, Department of Surgery, Nottingham University Hospitals, Nottingham City Hospital Campus, Nottingham, NG5 1PB, UK. Tel: +44-115-969-1169; Fax: +44-115-962-7764; E-mail: biodunayantunde{at}yahoo.co.uk

Background: Malignant ascites is a manifestation of end stage events in a variety of cancers and associated with a poor prognosis. We evaluated the pattern of cancers causing malignant ascites and factors affecting survival.

Patients and methods: Patients coded with the International Classification of Diseases-9 coding system for malignant ascites over a 2-year period were reviewed. The clinicopathological data and patients' survival were compared among cancer groups.

Results: There were 209 patients (140 females and 69 males), median age being 67 (30–98) years. The commonest cancer was ovarian followed by gastrointestinal (GI) cancers. Fifty-eight per cent of the patients had symptoms related to the ascites. Liver metastases were significantly commoner in the GI cancers (P = 0.0001). Fifty-four per cent of our patients presented with ascites at the initial diagnosis of their cancer. Paracentesis was given to 112, diuretics to 70 and chemotherapy to 103 patients. The median survival following diagnosis of ascites was 5.7 months. Ovarian cancer favoured longer survival while low serum albumin, low serum protein and liver metastases adversely affected survival. The independent prognostic factors for survival were cancer type, liver metastases and serum albumin.

Conclusion: The identified independent prognostic factors should be used to select patients for multimodality therapy for adequate palliation.

Key words: cancers, chemotherapy, malignant ascites, paracentesis, prognotic factors, survival

Received for publication August 10, 2006. Revision received November 3, 2006. Revision received December 11, 2006. Accepted for publication December 15, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.